Cargando…
Mast Cells Are Mediators of Fibrosis and Effector Cell Recruitment in Dermal Chronic Graft-vs.-Host Disease
Allogeneic hematopoietic stem cell transplant (allo-HSCT) is often used to treat acute leukemia or defects of hematopoiesis. Its widespread use is hampered by graft-vs.-host disease (GVHD), which has high morbidity and mortality in both acute and chronic subtypes. Chronic GVHD (cGVHD) occurs most fr...
Autores principales: | Strattan, Ethan, Palaniyandi, Senthilnathan, Kumari, Reena, Du, Jing, Hakim, Natalya, Huang, Timothy, Kesler, Melissa V., Jennings, C. Darrell, Sturgill, Jamie L., Hildebrandt, Gerhard C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6813249/ https://www.ncbi.nlm.nih.gov/pubmed/31681336 http://dx.doi.org/10.3389/fimmu.2019.02470 |
Ejemplares similares
-
S242: MAST CELLS ARE MEDIATORS OF INFLAMMATORY EFFECTOR CELL RECRUITMENT AND FIBROSIS IN DERMAL CHRONIC GRAFT-VERSUS-HOST DISEASE
por: Palaniyandi, Senthilnathan, et al.
Publicado: (2023) -
Microbiome: an emerging new frontier in graft‑versus‑host disease
por: Kumari, Reena, et al.
Publicado: (2020) -
Mast Cell Involvement in Fibrosis in Chronic Graft-Versus-Host Disease
por: Strattan, Ethan, et al.
Publicado: (2021) -
Metabolic Reprogramming—A New Era How to Prevent and Treat Graft Versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Has Begun
por: Kumari, Reena, et al.
Publicado: (2020) -
Time to relapse in chronic lymphocytic leukemia and DNA-methylation-based biological age
por: Nannini, Drew R., et al.
Publicado: (2023)